MENU
+Compare
VCYT
Stock ticker: NASDAQ
AS OF
Sep 23 closing price
Price
$34.15
Change
+$0.22 (+0.65%)
Capitalization
2.69B

VCYT Veracyte Forecast, Technical & Fundamental Analysis

Veracyte Inc is a genomic diagnostics company... Show more

Industry: #Biotechnology
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VCYT with price predictions
Sep 23, 2025

VCYT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for VCYT turned positive on September 18, 2025. Looking at past instances where VCYT's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 29, 2025. You may want to consider a long position or call options on VCYT as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VCYT advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 139 cases where VCYT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for VCYT moved out of overbought territory on September 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCYT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VCYT broke above its upper Bollinger Band on September 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VCYT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.200) is normal, around the industry mean (9.395). P/E Ratio (100.441) is within average values for comparable stocks, (136.503). VCYT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.692). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (5.688) is also within normal values, averaging (9.148).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VCYT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VCYT is expected to report earnings to fall 27.36% to 31 cents per share on November 11

Veracyte VCYT Stock Earnings Reports
Q3'25
Est.
$0.32
Q2'25
Beat
by $0.33
Q1'25
Beat
by $0.29
Q4'24
Beat
by $0.26
Q3'24
Beat
by $0.30
The last earnings report on August 06 showed earnings per share of 43 cents, beating the estimate of 10 cents. With 748.17K shares outstanding, the current market capitalization sits at 2.69B.
A.I. Advisor
published General Information

General Information

a company that discovers, develops and commercializes molecular diagnostic solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
6000 Shoreline Court
Phone
+1 650 243-6300
Employees
815
Web
https://www.veracyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLVPX20.120.06
+0.30%
MFS Low Volatility Equity R3
FAKDX9.62N/A
N/A
Kempner Multi-Cap Deep Value Investor
BIVSX17.47-0.07
-0.40%
Invenomic Super Institutional
JANBX51.22-0.27
-0.52%
Janus Henderson Balanced D
VMGRX29.57-0.18
-0.61%
Vanguard Mid Cap Growth Inv

VCYT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been loosely correlated with GH. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VCYT jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
-0.53%
GH - VCYT
53%
Loosely correlated
+1.07%
NTRA - VCYT
53%
Loosely correlated
-1.06%
TWST - VCYT
51%
Loosely correlated
-0.29%
ILMN - VCYT
50%
Loosely correlated
-1.23%
A - VCYT
49%
Loosely correlated
+0.01%
More